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This is a timely booklet sponsored by the International Association for the Improvement of Mental Health Programmes and funded by an Eli Lilly unrestricted educational grant. It is an extensive literature review on physical comorbidity in schizophrenia, based on an initial screening of 44 567 abstracts in all languages. The review was prompted by an increasing appreciation of the high mortality rate in schizophrenia: those diagnosed with schizophrenia die 15 years, on average, before their peers. Although suicide and accidents account for about 40% of the excess in mortality, the remaining 60% are due to premature death secondary to illness.
The book systematically looks at 23 disease categories and reports their prevalence among those with schizophrenia, a major task that must have taken some time. Although the references are relatively up-to-date, many more have been added since the writing of this book was completed, as interest in this phenomenon is growing exponentially.
The authors speculate on the causes of the increased comorbidity. They list disease-related factors such as negative symptoms that may prevent help seeking and treatment adherence, cognitive disturbance that interferes with the ability to communicate with care providers, and lifestyle issues (for example, smoking, substance abuse, diet, and lack of exercise) that contribute to ill health. A possibility not mentioned is that whatever contributes to the development of schizophrenia may also affect the pace of aging (Down syndrome is an example of this phenomenon) and wear and tear on tissues. The likelihood of this connection has not yet been investigated.
The section on causative factors related to drug treatment is very much underplayed in this book, a curious fact as most comorbidities are directly related to weight gain, cardiac irregularity, and prolactin excess secondary to drug treatment. Even so-called lifestyle choices (smoking and substance abuse) are probably provoked and sustained by the side effects of psychiatric drugs.
The authors do address the role of system-related factors and the stigma of mental illness as contributory factors in that, in many countries, the lack of insurance coverage may prevent help seeking and that access to health care may be decreased because of stigma. The gap that still exists between psychiatry and other medical specialties and the relative lack of medical expertise among psychiatrists are also emphasized. Also mentioned is the tendency of mental health workers to dismiss physical complaints as psychosomatic in nature, although this appears to be changing.
The poverty that results from the cognitive difficulties and subsequent unemployment of those with schizophrenia is another important factor, leading to residential overcrowding and poor hygiene (both in hospital and in the community), and predisposing to infection.
Whatever the causes, this booklet reminds clinicians that physical illness in those with schizophrenia cannot be ignored. In the Canadian context, close liaison with families and with general practitioners, intensive social work involvement or case management, an emphasis on prevention, diet, and exercise, and very careful management of psychiatric medication (avoidance of polypharmacy, low doses, and reconsideration of older medications) are essential. As a profession, psychiatry also needs to support the development of safer drugs and to advocate for a higher standard of living for the population that suffers from serious mental illness.
